Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03984669Completed
Single-arm trial, sponsored by CHU Amiens-Picardie. Primary endpoint: (1,3)-Beta-D-Glucan Level at 1 year. Started Jun 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03984669.